May 13, 2026
Rivermark Medical
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
- Round
- Series D
- Amount raised
- $20M
- Lead investor
- American Century Investments
- Industry
- Health Care
- Headquarters
- Milwaukee, United States
- Employees
- 1-10
- Website
- www.rivermarkmedical.com
- View profile →
Other investors
- Andera Partners
- Anduril Investors
- Clarevia Ventures
- TIME BioVentures
Source: Crunchbase snapshot 2026-05-15